معرفی
Dr Alison Killen is an academic affiliated with Newcastle University, focusing on dementia research, particularly in Lewy body dementia and Parkinson's disease with dementia. Her work emphasizes neurophysiological mechanisms, clinical interventions, and psychosocial support for patients and caregivers. She collaborates extensively with interdisciplinary teams to explore cognitive dysfunction, visual hallucinations, and the impact of neurodegenerative diseases on quality of life.
Her research spans structural and functional brain imaging, electrophysiological studies (EEG), and clinical trials of interventions. Notable contributions include exploring bottom-up visual processing deficits, EEG-based biomarkers for differential diagnosis, and the development of psychosocial support programs for dementia patients and their families. Dr. Killen has also investigated the challenges faced by dementia patients and caregivers during the COVID-19 pandemic.
Her publications highlight a commitment to translational research, bridging basic neuroscience with clinical applications. Collaborations with institutions like Premier League clubs demonstrate her interest in community-based interventions. Dr. Killen’s work often addresses unmet needs in dementia care, including attention deficits, caregiver education, and the underrepresentation of visual symptoms in diagnostic frameworks.
While no formal awards are listed, her consistent output in high-impact areas underscores her expertise in neurodegenerative diseases. Her research themes include improving diagnostic accuracy, understanding hallucination mechanisms, and enhancing patient well-being through multidisciplinary approaches.
